Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU)
Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU) A Case Series of Initial Effectiveness and Safety Measures
Sponsor: Acera Surgical, Inc.
A NA clinical study on Diabetic Foot Ulcer, this trial is completed. The trial is conducted by Acera Surgical, Inc. and has accumulated 12 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Oct 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Oct 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
▶ Show 7 earlier versions
-
May 2021 — Dec 2022 [monthly]
Completed NA
-
Jan 2021 — May 2021 [monthly]
Completed NA
-
Feb 2020 — Jan 2021 [monthly]
Completed NA
-
Sep 2018 — Feb 2020 [monthly]
Completed NA
Status: Recruiting → Completed
-
Jun 2018 — Sep 2018 [monthly]
Recruiting NA
-
Feb 2018 — Jun 2018 [monthly]
Recruiting NA
-
Nov 2017 — Feb 2018 [monthly]
Recruiting NA
First recorded
Sep 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Acera Surgical, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .